This study identifies naturally processed peptides bound to HLA-DR alleles, revealing their origin, sequence, and binding characteristics. Over 200 unique peptide masses were identified from each of five HLA-DR alleles (DR2, DR3, DR4, DR7, DR8), with a total of 201 peptide sequences obtained. These peptides, derived from 66 different source proteins, were mostly endogenous and related to the endocytic/class II pathway, despite the class II molecules' primary role in presenting exogenous antigens. Promiscuous self-peptides capable of binding to multiple HLA-DR alleles were identified, along with 84 allele-specific peptide sets. Binding experiments confirmed that promiscuous peptides have high affinity for all HLA-DR alleles examined. The study suggests a potential physiological role for these endogenous self-peptides as immunomodulators of the cellular immune response. The study also highlights the differences in peptide binding between class I and class II MHC molecules. Class II molecules have a more open binding groove, allowing for longer peptides (13–25 residues) compared to class I (12–15 residues). Peptides derived from endogenous and exogenous proteins were identified, with a significant proportion coming from MHC-related molecules. The study also identified peptides from various proteins, including those from the invariant chain (Ii), HLA-DR α chain, and Ig κ chain. These peptides were found to be nested at both the amino- and carboxy-terminal ends, suggesting a specific binding pattern. The study further demonstrates that peptides derived from different sources can bind to multiple HLA-DR alleles, indicating a degree of promiscuity in peptide binding. The binding of these peptides to HLA-DR molecules was confirmed using flow cytometry and competitive inhibition experiments. The results suggest that these peptides may play a role in modulating the immune response by competing with antigenic peptides for binding sites on MHC molecules. The study also identifies specific motifs for peptide binding to HLA-DR alleles, with some peptides showing strict allele-specific binding. However, the identification of these motifs is challenging due to the variability in peptide length and sequence. The study concludes that the binding of peptides to HLA-DR molecules is influenced by the composition and location of key amino acids within the primary structure of the peptides. The study provides insights into the complex process of antigen processing and peptide binding in vivo, highlighting the importance of understanding the interactions between peptides and MHC molecules in the immune response.This study identifies naturally processed peptides bound to HLA-DR alleles, revealing their origin, sequence, and binding characteristics. Over 200 unique peptide masses were identified from each of five HLA-DR alleles (DR2, DR3, DR4, DR7, DR8), with a total of 201 peptide sequences obtained. These peptides, derived from 66 different source proteins, were mostly endogenous and related to the endocytic/class II pathway, despite the class II molecules' primary role in presenting exogenous antigens. Promiscuous self-peptides capable of binding to multiple HLA-DR alleles were identified, along with 84 allele-specific peptide sets. Binding experiments confirmed that promiscuous peptides have high affinity for all HLA-DR alleles examined. The study suggests a potential physiological role for these endogenous self-peptides as immunomodulators of the cellular immune response. The study also highlights the differences in peptide binding between class I and class II MHC molecules. Class II molecules have a more open binding groove, allowing for longer peptides (13–25 residues) compared to class I (12–15 residues). Peptides derived from endogenous and exogenous proteins were identified, with a significant proportion coming from MHC-related molecules. The study also identified peptides from various proteins, including those from the invariant chain (Ii), HLA-DR α chain, and Ig κ chain. These peptides were found to be nested at both the amino- and carboxy-terminal ends, suggesting a specific binding pattern. The study further demonstrates that peptides derived from different sources can bind to multiple HLA-DR alleles, indicating a degree of promiscuity in peptide binding. The binding of these peptides to HLA-DR molecules was confirmed using flow cytometry and competitive inhibition experiments. The results suggest that these peptides may play a role in modulating the immune response by competing with antigenic peptides for binding sites on MHC molecules. The study also identifies specific motifs for peptide binding to HLA-DR alleles, with some peptides showing strict allele-specific binding. However, the identification of these motifs is challenging due to the variability in peptide length and sequence. The study concludes that the binding of peptides to HLA-DR molecules is influenced by the composition and location of key amino acids within the primary structure of the peptides. The study provides insights into the complex process of antigen processing and peptide binding in vivo, highlighting the importance of understanding the interactions between peptides and MHC molecules in the immune response.